Resultado de búsqueda
27 de feb. de 2023 · Helixor® Helixor® preparations are non-fermented, aqueous fresh plant extracts from two and a half years old mistletoe shoots (leaves, stems, flowers, berries). They are harvested four times a year (winter, spring, summer and autumn) to take into account different stages of plant development and to include all the seasonally different constituents.
Santa Clause, mistletoe, Christmas roses, Christmas baubles, fairy lights… and most importantly: plenty of lovely people. We’ve already prepared everything for you for the Christmas season: Just click to find lots of (lovely) people from the Helixor team who send you Christmas Greetings.
Since 1975, Helixor has been a leading pharmaceutical company in the field of integrative oncology. Physicians, patients, family members, and our partners in over 30 countries trust in our long-term therapy concepts. Helixor therapies are part of integrative oncology. They expand conventional oncology into a more relationship-oriented, holistic ...
An increasing number of cancer patients trust mistletoe therapy, which frequently improves the tolerability of conventional cancer therapies and quality of life. Mistletoe therapy strengthens the immune system, reduces fatigue, normalizes moods, sleep patterns, and body temperature, among other effects. You can do more for yourself.
8 de jun. de 2023 · Mistletoe, a semiparasitic plant that grows on several types of trees such as apple, oak, pine and elm, is commonly used in cancer patients in Europe. Read about laboratory and human studies of extracts, such as Iscador and Eurixor, and their effects on quality of life, survival and symptom relief in this expert-reviewed summary.
Our products have the required drug approvals in Germany. Please ask us whether this is the case for your country. Our full range of products is not available in all countries. Die Helixor Heilmittel GmbH ist spezialisiert auf 2 Kerntherapien der integrativen Onkologie Misteltherapie und Helleborustherapie Mehr erfahren!
22 de feb. de 2023 · Mistletoe extract (ME), known as Helixor M, was studied in 21 patients with advanced and treatment-resistant cancers of various types. The phase I trial used dose escalation to determine the maximum dose that could be safely tolerated by patients. ME was delivered intravenously three times per week until disease progression or until toxicity.
